专利信息

首页 1 2 3 4 5 6 下页尾页共 152 条记录, 当前第1/16页。

专利标题：Compositions containing salmeterol, fluticasone and cromoglicic acid

The present invention relates to the use of cromoglicic acid and/or nedocromil salts in pharmaceutically effective amounts in a pharmaceutical composition containing salmeterol or a pharmaceutically acceptable salt thereof as a 32-agonisti combined with fluticasone or a pharmaceutically acceptable salt thereof as a corticosteroid for the treatment of the respiratory diseases.

专利标题：COMPOSITIONS CONTAINING SALMETEROL, FLUTICASONE AND CROMOGLICIC ACID

专利权人：BILGIC MAHMUT [TR];

专利标题：A kind of preparation method of sodium nedocromil

专利标题：Compositions containing salmeterol, fluticasone and cromoglicic acid

专利权人：Mahmut Bilgic;

The present invention relates to the use of cromoglicic acid and/or nedocromil salts in pharmaceutically effective amounts in a pharmaceutical composition containing salmeterol or a pharmaceutically acceptable salt thereof as a β.sub.2-agonisti combined with fluticasone or a pharmaceutically acceptable salt thereof as a corticosteroid for the treatment of the respiratory diseases.

专利标题：Compositions comprising a corticosteroid, a beta2 agonist as well as cromoglicic acid or ndeocromil

专利权人：Bilgic, Mahmut;

The present invention relates to a pharmaceutical composition for use in the treatment of respiratory diseases characterized in that said composition comprises a pharmaceutically effective amount of cromoglicic acid and/or nedocromil salts besides β2-agonists and corticosteroid drugs.

专利标题：Aerosol formulation for medicine

The use of solid pharmaceutically acceptable salts of cromoglycic acid and/or nedocromil as carriers in a therapeutically and prophylactically inefficacious amount in suspension aerosol formulations of pharmaceutical active compounds improves the dispersion properties increases the chemical and physical stability of moisture-sensitive active compounds makes possible a more accurate dosage in particular even of low-dose active compounds and as a rule permits the abandonment of surface-active agen...

专利标题：[4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il]-[7-fluoro-1-(2-metoxi-etil)-4-trifluorometoxi-1h-indol-3-il]-metanona como un inhibidor de la triptasa de mastocitos

专利权人：Sanofi-aventis;

SE REFIERE A UN COMPUESTO DE INDOL BENCILAMINA SUSTITUIDO DE FORMULA (I) Y A UNA FORMA CRISTALINA A DE DICHO COMPUESTO QUE TIENE PICOS DE XRPD EXPRESADOS EN GRADOS 2 THETA DE 775; 1013; 1703; 1716; 1839; 2133 Y 2188. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE A) EL COMPUESTO DE FORMULA (I); Y B) UN SEGUNDO COMPUESTO TAL COMO i) UN AGONISTA BETA ADRENERGICO TAL COMO ALBUTEROL TERBUTALINA FORMOTEROL ENTRE OTROS; ii) UN ANTICOLINERGICO TAL COMO BROMURO DE IPRATROPIO O TIOTROPIO...

专利标题：Synthesis, anti-allergic, anti-asthmatic and anti-inflammatory activities of cee-1 and cee-2

专利权人：Kuwait University;

“Enhydrazone esters of formula (I): wherein R is methyl or ethyl group have been synthesized. The compounds of formula (I) are potent inhibitors of degranulation of both mast cells and eosinophils. These compounds also suppress cytokines generation by leukocytes. These biological activities are relevant to the prevention and/or treatment of asthma allergies and inflammatory diseases. It is known to the art that inhibitors of mast cell degranulation such as cromolyn sodium and nedocromil sodium a...

专利标题：Pharmaceutical compositions comprising an amphoteric surfactant an alkoxylated cetyl alcohol and a polar drug

专利权人：Hewlett Healthcare Limited;

A formulation for example an oil-in-water emulsion comprising an amphoteri c surfactant alkoxylated cetyl alcohol and a polar drug. The drug may be sodium cromoglycate or nedocromil sodium. The formulation may be useful in the treatment of skin disease such as atopic dermatitis.

专利标题：The amphoteric surface active agent, arukokishiru conversion cetyl alcohol and the medicine composition which includes the polarity medicine

A formulation for example an oil-in-water emulsion comprising an amphoteric surfactant alkoxylated cetyl alcohol and a polar drug.The drug may be sodium cromoglycate or nedocromil sodium.The formulation may be useful in the treatment of skin disease such as atopic dermatitis.(From US7109246 B1)

当前查询条件: [药品] 包含 'Nedocromil'

	查询范围	在当前结果中查询
!	专利类型	发明实用新型外观设计
!	公开号			CN1234
!	申请号			CN1234
!	专利标题		扩展	PHARMA
!	专利权人		扩展	pfizer
	发明人
!	申请日			yyyymmdd
!	公开日			yyyymmdd
	优先权号
!	摘要		扩展	PHARMA
	IPC			A01B

1. US20130022650A1	2013/1/24	US13/519018	2010/12/20
专利标题：Compositions containing salmeterol, fluticasone and cromoglicic acid 专利权人： The present invention relates to the use of cromoglicic acid and/or nedocromil salts in pharmaceutically effective amounts in a pharmaceutical composition containing salmeterol or a pharmaceutically acceptable salt thereof as a 32-agonisti combined with fluticasone or a pharmaceutically acceptable salt thereof as a corticosteroid for the treatment of the respiratory diseases.

2. US2013022650A1	2013/1/24	US201013519018	2010/12/20
专利标题：COMPOSITIONS CONTAINING SALMETEROL, FLUTICASONE AND CROMOGLICIC ACID 专利权人：BILGIC MAHMUT [TR]; The present invention relates to the use of cromoglicic acid and/or nedocromil salts in pharmaceutically effective amounts in a pharmaceutical composition containing salmeterol or a pharmaceutically acceptable salt thereof as a 32-agonisti combined with fluticasone or a pharmaceutically acceptable salt thereof as a corticosteroid for the treatment of the respiratory diseases.

3. CN102516252A	2012/6/27	CN20111438908	2011/12/23
专利标题：A kind of preparation method of sodium nedocromil 专利权人：Sichuan Dihon Medical Development Co., Ltd.;

4. WO2011078823A1	2011/6/30	WO2010TR00250	2010/12/20
专利标题：Compositions containing salmeterol, fluticasone and cromoglicic acid 专利权人：Mahmut Bilgic; The present invention relates to the use of cromoglicic acid and/or nedocromil salts in pharmaceutically effective amounts in a pharmaceutical composition containing salmeterol or a pharmaceutically acceptable salt thereof as a β.sub.2-agonisti combined with fluticasone or a pharmaceutically acceptable salt thereof as a corticosteroid for the treatment of the respiratory diseases.

5. WO2011049539A1	2011/4/28	WO2010TR00208	2010/10/20
专利标题：Compositions comprising a corticosteroid, a beta2 agonist as well as cromoglicic acid or ndeocromil 专利权人：Bilgic, Mahmut; The present invention relates to a pharmaceutical composition for use in the treatment of respiratory diseases characterized in that said composition comprises a pharmaceutically effective amount of cromoglicic acid and/or nedocromil salts besides β2-agonists and corticosteroid drugs.

6. JP4672143B2	2011/4/20	JP20000563253	1999/8/2
专利标题：Aerosol formulation for medicine 专利权人： The use of solid pharmaceutically acceptable salts of cromoglycic acid and/or nedocromil as carriers in a therapeutically and prophylactically inefficacious amount in suspension aerosol formulations of pharmaceutical active compounds improves the dispersion properties increases the chemical and physical stability of moisture-sensitive active compounds makes possible a more accurate dosage in particular even of low-dose active compounds and as a rule permits the abandonment of surface-active agen...

7. PE02352010A1	2010/3/29	PE20090103520	2009/8/20
专利标题：[4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il]-[7-fluoro-1-(2-metoxi-etil)-4-trifluorometoxi-1h-indol-3-il]-metanona como un inhibidor de la triptasa de mastocitos 专利权人：Sanofi-aventis; SE REFIERE A UN COMPUESTO DE INDOL BENCILAMINA SUSTITUIDO DE FORMULA (I) Y A UNA FORMA CRISTALINA A DE DICHO COMPUESTO QUE TIENE PICOS DE XRPD EXPRESADOS EN GRADOS 2 THETA DE 775; 1013; 1703; 1716; 1839; 2133 Y 2188. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE A) EL COMPUESTO DE FORMULA (I); Y B) UN SEGUNDO COMPUESTO TAL COMO i) UN AGONISTA BETA ADRENERGICO TAL COMO ALBUTEROL TERBUTALINA FORMOTEROL ENTRE OTROS; ii) UN ANTICOLINERGICO TAL COMO BROMURO DE IPRATROPIO O TIOTROPIO...

8. US20090253786A1	2009/10/8	US12/098460	2008/4/7
专利标题：Synthesis, anti-allergic, anti-asthmatic and anti-inflammatory activities of cee-1 and cee-2 专利权人：Kuwait University; “Enhydrazone esters of formula (I): wherein R is methyl or ethyl group have been synthesized. The compounds of formula (I) are potent inhibitors of degranulation of both mast cells and eosinophils. These compounds also suppress cytokines generation by leukocytes. These biological activities are relevant to the prevention and/or treatment of asthma allergies and inflammatory diseases. It is known to the art that inhibitors of mast cell degranulation such as cromolyn sodium and nedocromil sodium a...

9. CA2330330C	2009/9/15	CA19992330330	1999/5/20
专利标题：Pharmaceutical compositions comprising an amphoteric surfactant an alkoxylated cetyl alcohol and a polar drug 专利权人：Hewlett Healthcare Limited; A formulation for example an oil-in-water emulsion comprising an amphoteri c surfactant alkoxylated cetyl alcohol and a polar drug. The drug may be sodium cromoglycate or nedocromil sodium. The formulation may be useful in the treatment of skin disease such as atopic dermatitis.

10. JP4230109B2	2009/2/25	JP20000550458	1999/5/20
专利标题：The amphoteric surface active agent, arukokishiru conversion cetyl alcohol and the medicine composition which includes the polarity medicine 专利权人： A formulation for example an oil-in-water emulsion comprising an amphoteric surfactant alkoxylated cetyl alcohol and a polar drug.The drug may be sodium cromoglycate or nedocromil sodium.The formulation may be useful in the treatment of skin disease such as atopic dermatitis.(From US7109246 B1)

下载范围

下载内容